Pharmacological breast cancer therapy (Review)

  • Authors:
    • Patrick M. Navolanic
    • James A. McCubrey
  • View Affiliations

  • Published online on: November 1, 2005     https://doi.org/10.3892/ijo.27.5.1341
  • Pages: 1341-1344
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Breast cancer ranks as the second most common cause of cancer death among women in the United States. Anticancer agents are an important component of breast cancer therapy. Drugs frequently used to treat breast cancer include methotrexate, 5-fluorouracil (5-FU), cyclophosphamide, anthracyclines, taxanes, trastuzumab, tamoxifen, and aromatase inhibitors. These agents inhibit breast cancer progression by a variety of different mechanisms. This review describes each of these drugs and the varying effects each of them have upon breast cancer cells.

Related Articles

Journal Cover

November 2005
Volume 27 Issue 5

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Navolanic PM and Navolanic PM: Pharmacological breast cancer therapy (Review). Int J Oncol 27: 1341-1344, 2005
APA
Navolanic, P.M., & Navolanic, P.M. (2005). Pharmacological breast cancer therapy (Review). International Journal of Oncology, 27, 1341-1344. https://doi.org/10.3892/ijo.27.5.1341
MLA
Navolanic, P. M., McCubrey, J. A."Pharmacological breast cancer therapy (Review)". International Journal of Oncology 27.5 (2005): 1341-1344.
Chicago
Navolanic, P. M., McCubrey, J. A."Pharmacological breast cancer therapy (Review)". International Journal of Oncology 27, no. 5 (2005): 1341-1344. https://doi.org/10.3892/ijo.27.5.1341